Group 1 - The company held its 32nd meeting of the second board of directors on July 11, 2025, with all 8 directors present, confirming the legality and validity of the meeting [1] - The board approved the adjustment of the company's organizational structure, including the cancellation of the nomination committee and the remuneration and assessment committee, integrating their responsibilities into a special meeting of independent directors [1] - The board also approved the revision of the company's articles of association to enhance governance and compliance with relevant laws and regulations, pending approval from the upcoming shareholders' meeting [2][3] Group 2 - The board approved the nomination of candidates for the third board of directors, including both non-independent and independent directors, with all nominations receiving unanimous support [4][5][6] - The third board of directors will serve a term of three years starting from the approval date at the shareholders' meeting, with the current board continuing to operate until the new board is elected [4][6] - A shareholders' meeting is scheduled for July 28, 2025, to discuss and vote on the proposed changes and nominations [7]

上海先惠自动化技术股份有限公司 董事、高级管理人员行为准则 第一章 总则 第一条 为了规范上海先惠自动化技术股份有限公司（以下简称"公司"或 "上市公司"）董事、高级管理人员的行为，完善公司治理，根据《中华人民共 和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》（以下 简称"《证券法》"）、 《上海证券交易所科创板股票上市规则》 （以下简称"《科 创板上市规则》"）、《上市公司治理准则》《上海证券交易所科创板上市公司 自律监管指引第1号——规范运作》（以下简称"《规范运作》"）等相关法律、 法规、规范性文件以及《上海先惠自动化技术股份有限公司章程》 （以下简称"《公 司章程》"）的规定，特制定本行为准则。 第二条 本准则适用于公司的董事、高级管理人员。 第三条 公司董事、高级管理人员应自觉学习《公司法》《证券法》及国家 有关法律、法规、规范性文件，不断提高自身素质和修养，增强法律意识和现代 企业经营意识，掌握最新政策导向和经济发展趋势。 第四条 公司董事、高级管理人员应当诚实守信，不得损害投资者特别是中 小投资者的合法权益。 第二章 声明与承诺 第五条 上市公司董事和高级管理人员应当在公司股票 ...

Core Points - Jiangsu Linyang Energy Co., Ltd. was established in accordance with the Company Law and Securities Law of the People's Republic of China, and it was registered in Nantong City, Jiangsu Province [1] - The company issued 75 million shares of ordinary stock to the public for the first time on August 8, 2011, and is listed on the Shanghai Stock Exchange [1] - The company engages in the research, development, manufacturing, and sales of various energy-related products, including photovoltaic equipment, smart grid systems, and energy storage systems [2] Group 1: Company Structure and Governance - The company is governed by its articles of association, which outline the responsibilities and rights of shareholders, directors, and senior management [2][13] - The legal representative of the company must be determined within 30 days of resignation [1] - The company is liable for civil damages caused by the legal representative while performing their duties, and it can seek compensation from the representative if they are at fault [2] Group 2: Business Scope - The company’s business scope includes the development, construction, maintenance, and management of photovoltaic power generation projects, as well as the import and export of various goods and technologies [2] - The company is involved in the research and production of energy-saving and environmental protection products [2] Group 3: Share Issuance and Management - The company can increase its capital through various methods, including issuing shares to unspecified or specific objects, distributing bonus shares, and converting reserves into capital [5] - The company can repurchase its shares under certain conditions, with a limit of 10% of the total issued shares [6][8] - Shareholders have the right to propose temporary motions and participate in decision-making processes during shareholder meetings [26][29] Group 4: Shareholder Rights and Responsibilities - Shareholders are entitled to dividends and other benefits proportional to their shareholdings and have the right to supervise the company's operations [13][14] - Shareholders holding more than 1% of the shares can request the audit committee to initiate legal proceedings if the company suffers losses due to violations of laws or regulations [17][18] - The company must ensure that shareholders' rights are protected and that they are treated equally [21]

西安陕鼓动力股份有限公司 会 议 议 案 目 录 关于修订《西安陕鼓动力股份有限公司章程》的议案 各位股东及股东代表： 根据新《公司法》 《上市公司章程指引》等上位法要求，结合公司实际情况， 西安陕鼓动力股份有限公司（以下简称"公司"）拟对章程中相关条款以及注册 资本内容适应性调整，具体情况如下： 一、注册资本变更情况 会议审议通过了《关于公司回购注销部分激励对象已获授但尚未解除限售的限制 性股票及调整回购价格的议案》，公司决定回购注销部分激励对象已获授但尚未 解除限售的限制性股票共计 2,124,541 股，2025 年 6 月 17 日注销实施完毕。 基于上述情况，公司注册资本由 1,725,599,033 元变更为 1,723,474,492 元。 二、《公司章程》具体修订内容 序号 《公司章程》修订前 《公司章程》修订后 第一条 为维护公司、股东和债权人的合法权 第一条 为维护公司、股东、职工和债权 人的合法权 益，规范公司的组织和行为，根据《中华人民 益，规范公司的组织和行为，根据《中 华人民共和国 华人民共和国证券法》（以下简称《证券法》） 国证券法》（以下简称《证券法》） 和其他有关规定， 和其 ...

烟台中宠食品股份有限公司 第一条 为规范公司治理，加强对控股子公司的管理，根据《中华人民共和国公司 法》、《中华人民共和国证券法》等法律、法规、规范性文件以及《公司章程》的有关 规定，结合公司实际情况，特制定本制度。 第二条 本制度所称母公司是指烟台中宠食品股份有限公司，控股子公司是指烟台 中宠食品股份有限公司控股或实际控制的公司，其设立形式包括： （一）全资子公司； （二）公司与其他公司、企业或自然人共同出资设立的，公司控股 50%以上（不含 （三）持有其股权在 50%以下但能够实际控制的公司。 本制度所称子公司也包括公司合并报表范围内的其他下属公司、企业。 第三条 母公司与子公司之间是平等的法人关系。母公司以其持有的股权份额，依 法对子公司享有资产受益，重大决策，选择管理者，股份处置等股东权利。 第四条 子公司应当根据《公司法》及有关法律法规的规定，建立健全法人治理结 构和运作制度。 第五条 公司与子公司之间是平等的法人关系。母公司以其持有的股权份额，依法 对子公司享有资产受益、重大决策、选择管理者、股份处置等股东权利，并负有对子公 司指导、监督和相关服务的义务。 第八条 母公司通过子公司股东会行使股东权 ...

烟台中宠食品股份有限公司 第一章 总则 第一条 为进一步完善法人治理结构，提高议事和办事效率，规范烟台中宠食品股 份有限公司（以下简称公司）总经理（总裁，下同）人员的行为，根据《中华人民共和 国公司法》、《上市公司治理准则》等法律、法规、规章和《烟台中宠食品股份有限公 司章程》的有关规定，结合公司实际，制定本细则。 第二条 本细则所称总裁人员，包括总裁、副总裁。本细则规定了公司总裁的责任、 总裁及副总裁的职权及分工、总裁办公会等内容。 第二章 总裁的任职资格和任免程序 第三条 公司设总裁一人，由董事会提名，董事会聘任或解聘。公司设副总裁 2 至 董事可以兼任总裁、副总裁或其它高级管理人员职务，但兼任总裁、副总裁或者其 它高级管理人员职务的董事不得超过公司董事总数的二分之一。 第四条 总裁每届任期三年，可以连聘连任。总裁对董事会负责。 第五条 总裁任职应当具备下列条件： （一）《公司法》第一百七十八条规定情形的人员，被国务院证券监督管理机构确 定为市场禁入者，并且禁入尚未解除的人员，以及被国务院证券监督管理机构或证券交 易所认定不适宜担任上市公司总裁的人员，不得担任本公司的总裁； （二）具有较丰富的经济理论知识 ...

烟台中宠食品股份有限公司 第一章 总 则 第一条 为明确公司董事会的职责权限，规范公司董事会的议事方式和决策程序， 促使公司董事和董事会有效地履行职责，提高公司董事会规范运作和科学决策水平，根 据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证券法》、 《上市公司章程指引》、《上市公司治理准则》、《深圳证券交易所股票上市规则》（以 下简称"《股票上市规则》"）、《深圳证券交易所上市公司自律监管指引第 1 号-- 主板上市公司规范运作》及《烟台中宠食品股份有限公司章程》 （以下简称"公司章程"） 等有关规定，制定本规则。 第二章 董事会的组成和职权 第二条 公司依法设立董事会，董事会对股东会负责。 第三条 公司董事会由九名董事组成。 董事会中兼任公司高级管理人员以及由职工代表担任的董事人数总计不得超过董 事总数的二分之一。 公司董事会中应当设置独立董事，独立董事人数不得少于董事会成员的三分之一； 公司董事会中设置一名职工代表董事，通过公司职工代表大会选举产生。 第四条 董事会行使下列职权： （一）召集股东会，并向股东会报告工作； （二）执行股东会的决议； （六）制订公司增加或减少注册资本、 ...

Meeting Overview - The company will hold its first extraordinary general meeting of shareholders for 2025 on July 15, 2025, at 10:00 AM [1] - The meeting will include both on-site voting and online voting options for shareholders [2] Voting Procedures - Shareholders can choose to vote in person or via online platforms provided by the Shenzhen Stock Exchange [2] - The online voting will be available from 9:15 AM to 3:00 PM on the same day [1][11] Agenda Items - The meeting will discuss several proposals, including the election of the fifth board of directors and amendments to various governance documents [3][4] - The election of non-independent directors and independent directors will be conducted through cumulative voting [4] Registration Requirements - Shareholders must register to attend the meeting, with specific documentation required for both corporate and individual shareholders [4][5] - Proxy voting is allowed, and the proxy does not need to be a shareholder of the company [2][4] Contact Information - Shareholders can contact the company's securities department for any inquiries related to the meeting [5]

Core Viewpoint - The ongoing power struggle within Kexing Biotech has reached a critical point, with significant implications for the company's future and its shareholders, particularly regarding the massive dividend payout and its impact on long-term growth potential [2][10]. Group 1: Shareholder Meeting and Dividend Controversy - A special shareholder meeting on July 9 resulted in a contentious vote to remove the current board and appoint a new one, with both sides claiming legitimacy [3]. - The current board, led by Li Jiaqiang, initiated a $7.5 billion dividend payout as a strategy to secure support from shareholders, while the opposing faction led by Yin Weidong sought to leverage the situation for a board takeover [3][4]. - The total dividend payout reached $124 per share, translating to a staggering yield of over 1900% based on the original purchase price of $6.47 per share [2]. Group 2: Historical Context and Governance Issues - The conflict traces back to a disagreement over privatization strategies in 2015, leading to a split between factions supported by different investment firms [4]. - The board's governance issues have led to significant operational disruptions, including a halt in research and development activities and the resignation of the independent auditing firm [6][8]. - The company has faced legal challenges, including a court ruling that invalidated a previous board's actions, further complicating its governance structure [4]. Group 3: Financial Performance and Future Outlook - Kexing Biotech reported a net profit of $8.467 billion in 2021, but has since experienced significant losses in 2023 and the first half of 2024 [8]. - Following the dividend payout, the company is left with approximately $2 to $3 billion in cash, which raises concerns about its ability to fund future research and development initiatives [8][10]. - Analysts express skepticism about the company's long-term viability without a clear growth strategy or new product pipeline, especially after the decline of its COVID-19 vaccine business [10].

General Provisions - Jiangsu Zhongshe Group Co., Ltd. is established as a joint-stock company in accordance with the Company Law and other relevant regulations [1] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 13.3335 million shares on June 20, 2017, and is listed on the Shenzhen Stock Exchange [1][2] - The registered capital of the company is RMB 156.157166 million [2] Business Objectives and Scope - The company's business objectives include striving for innovation, pursuing excellence, honesty, and mutual development [3] - The business scope includes construction engineering consulting services, project management, engineering supervision, and various engineering-related activities [3] Shares - The company's shares are issued in the form of stocks, with a total of 156.157166 million shares issued, all of which are ordinary shares [5][6] - The company can increase capital through various methods, including issuing shares to unspecified objects or existing shareholders [6] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, request meetings, supervise company operations, and transfer their shares [10] - Shareholders must comply with laws and the company's articles of association, and they are liable for their subscribed shares [16] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting required to be held within six months after the end of the previous fiscal year [19] - Shareholder meetings are the company's decision-making body, with specific powers including electing directors, approving profit distribution plans, and modifying the articles of association [47] Voting and Resolutions - Resolutions can be classified as ordinary or special, with ordinary resolutions requiring a simple majority and special resolutions requiring a two-thirds majority [81][82] - Shareholders exercise voting rights based on the number of shares they hold, with each share granting one vote [84]